Search For "bharat biotech covaxin"
Vice President congratulates Bharat Biotech, ICMR for WHO's emergency use
Updated : 4 years, 4 months ago IST
New Delhi [India], November 3 (ANI): Vice President M Venkaiah Naidu on Wednesday congratulated Bharat Biotech and ICMR for developing Covaxin which got World Health Organization's (WHO) nod for emergency use on Wednesday.
Read More
After Covaxin gets WHO's EUL status, Bharat Biotech chief thanks PM Modi
Updated : 4 years, 4 months ago IST
New Delhi [India], November 3 (ANI): After Bharat Biotech's Covaxin, was granted Emergency Use Listing (EUL) by the World Health Organization (WHO) on Wednesday, Dr. Krishna Ella, chairman and MD of the Hyderabad-based vaccine manufacturer said the validation was a "momentous occasion for In
Read More
WHO approval will expedite Covaxin regulatory approval in other countries:
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], November 3 (ANI): The approval of the World Health Organisation (WHO) for emergency use listing of Covid-19 vaccine COVAXIN, will lead to the expedition of regulatory approval of India's indigenously made vaccine all across the world, said the vaccine manufactu
Read More
Guyana adds Bharat Biotech's Covaxin to list of recognised COVID-19 vaccin
Updated : 4 years, 4 months ago IST
Georgetown [Guyana], November 2 (ANI): Guyana has recognised Bharat Biotech's Covaxin COVID-19 vaccine, said High Commission of India in Georgetown, Guyana on Tuesday.
Read More
Germany will take next step after WHO's approval of Covaxin, says envoy Li
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): German Ambassador to India, Walter J Lindner on Sunday asserted that his country would take the next step regarding Covaxin as soon as World Health Organization (WHO) would recognise Bharat Biotech's COVID vaccine to treat the virus.
Read More
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Read More
75 mn Covaxin doses supplied, more by September, says Bharat Biotech's Suc
Updated : 4 years, 7 months ago IST
New Delhi [India], August 12 (ANI): Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
Read More
Initial hiccups in Bharat Biotech Banglaore plant delayed Covaxin producti
Updated : 4 years, 7 months ago IST
New Delhi [India], August 2 (ANI): India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group (NTAGI) said and added that some hiccups like initial difficulties in the new Bangalore plant of Bhara
Read More
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Brazil to suspend Covaxin vaccine deal
Updated : 4 years, 8 months ago IST
Brasilia [Brazil], June 30 (ANI): Amid a probe into accusations of irregularities against President Jair Bolsonaro, Brazil's health minister has announced that the country will suspend a USD 324 million contract to buy 20 million doses of Bharat Biotech's Covaxin.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More